Home
OBI Pharma

OBI Pharma Market Share Analysis for May 2026

Organization of the Auditor’s Office (IA) The Company’s Internal Audit task force is comprised of full-time internal auditors and is directly under the Board of Directors. The chief auditor reports audit performance to each independent director on a regular basis and attends the board meeting to report the status of internal controls. The main purposes […]

Health > Biotechnology and Pharmaceuticals

Domainobipharma.com

Year Founded2002

Employees51 - 200

Annual Revenue$25M - $50M

OBI Pharma

OBI Pharma (including company regionals)

obipharma.com

See more website traffic and engagement information

OBI Pharma Revenue up to May 2026 is 25M - 50M

revenue generated by OBI Pharma top domains

OBI Pharma top domains revenue over 3 years

Revenue for OBI Pharma top domains

obipharma.com25M - 50M

See more with Sales Intelligence

Total visits to OBI Pharma's top domains

Understand OBI Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

obipharma.com5.4K

See more with Sales Intelligence

Avg. visit duration in OBI Pharma's top domains

Analyze OBI Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

obipharma.com00:00:31

See more with Sales Intelligence

Avg. pageviews on OBI Pharma's top domains

See how OBI Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

obipharma.com1.70

See more with Sales Intelligence

OBI Pharma top competitors by domain

Top similar sites in May 2026, ranked by their affinity

oep.com.twCompany NameOrient EuroPharma Co., Ltd.Employees501 - 1000HQTaiwan, TaipeiAnnual revenue--Total visits302Health > Biotechnology and Pharmaceuticals

Top technologies used by OBI Pharma

These are the website technologies, by industry, used by OBI Pharma top domains

Widget (5)

Twemoji

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from OBI Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOBI Pharma, Inc. launches GlycOBIR glycan site-specific conjugation technology at 5th World ADC Summit South Korea.During the conference, OBI Pharma's Senior Director of ADC Key Technology, Huang Dengyi, introduced the application of GlycOBIR glycan site-specific conjugation technology in homogeneous ADC design and DAR regulation, and shared the 'plug-and-play' characteristic of the GlycOBI DUOR platform, which can precisely connect two different payloads to a single antibody to create a dual-drug ADC with multiple mechanisms of action.

NewsOBI Pharma, Inc. attended event AACR 2026 on Apr 15th '26.TAIPEI, TW / ACCESS Newswire / April 15, 2026 / OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI(R) platform.

NewsOBI Pharma, Inc. partners with Nippon Fine Chemical Co..TAIPEI, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) - Amaran Biotechnology Inc., a subsidiary of OBI Pharma specializing in Contract Development and Manufacturing Organization (CDMO) services for next-generation pharmaceuticals, announced today that it has signed a Memorandum of Understanding (MOU) with Nippon Fine Chemical Co., Ltd., and its Taiwan subsidiary, Zillion Fine Chemicals International Co., Ltd.